In 2023, Hagens Berman took a stand against some of the world’s biggest pharmaceutical companies, automotive manufacturers and other powerful entities on behalf of people around the world. Through class-action litigation, the firm recovered billions of dollars in settlements in cases regarding alleged fraud, negligence, price-fixing and other corporate wrongdoing. The firm’s work continued to drive positive change in the areas of data privacy, prescription drug pricing, antitrust law and more.
Hagens Berman is proud to present the results of a year’s worth of tenacious, purposeful legal work toward a brighter and more just future.